Clinical and histological differences in anaplastic thyroid carcinoma
- PMID: 10688214
- DOI: 10.1080/110241500750009672
Clinical and histological differences in anaplastic thyroid carcinoma
Abstract
Objective: To report our experience in patients with anaplastic thyroid carcinoma and try to establish differences between cases in which the histological study showed that there was an associated thyroid carcinoma and those that were strictly anaplastic or pure.
Design: Retrospective study.
Setting: University hospital, Spain.
Subjects: 14 patients with anaplastic thyroid cancer treated over a period of 26 years; 7 presented with associated thyroid tumours and 7 were pure.
Mean outcome measures: Clinical data (age, sex, symptoms), treatment, histological study (associated thyroid disease, spread, involved lymph nodes) and follow-up.
Results: 13 of the 14 tumours had spread locally. 5 patients were treated by total thyroidectomy, 3 subtotal thyroidectomy, 5 excision of the tumour, and 1 patient had a biopsy alone. There were associated thyroid tumours in 7 cases: 2 follicular, 2 tall cell papillary, 1 solid papillary, 1 medullary and 1 Hurthle cell tumour. 12 patients died. Another 2 are still alive having survived 61 and 70 months respectively, both with associated anaplastic cancers (follicular and solid). The mean survival was 14 months (24 for associated anaplastic carcinoma and 4 for pure anaplastic carcinoma).
Conclusion: There is a subgroup of anaplastic cancers in which a better differentiated thyroid carcinoma coexists with the anaplastic carcinoma. The prognosis in this subgroup is better than that for primary pure anaplastic carcinoma.
Similar articles
-
Management and outcome of recurrent well-differentiated thyroid carcinoma.Arch Otolaryngol Head Neck Surg. 2004 Jul;130(7):819-24. doi: 10.1001/archotol.130.7.819. Arch Otolaryngol Head Neck Surg. 2004. PMID: 15262757
-
Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation.Clin Endocrinol (Oxf). 2004 Jul;61(1):145-8. doi: 10.1111/j.1365-2265.2004.02065.x. Clin Endocrinol (Oxf). 2004. PMID: 15212657
-
[Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].Praxis (Bern 1994). 2000 Nov 2;89(44):1779-97. Praxis (Bern 1994). 2000. PMID: 11109916 German.
-
Association of primary hyperparathyroidism and non-medullary thyroid cancer.Eur J Surg. 1996 Sep;162(9):685-9. Eur J Surg. 1996. PMID: 8908448 Review.
-
[Anaplastic carcinoma of the thyroid at the Instituto Nacional de la Nutrición Salvador Zubirán].Rev Invest Clin. 1997 Mar-Apr;49(2):97-103. Rev Invest Clin. 1997. PMID: 9380971 Review. Spanish.
Cited by
-
Treatment of patients with anaplastic thyroid cancer during the last 20 years: whether any progress has been made?Eur Arch Otorhinolaryngol. 2015 Jul;272(7):1553-67. doi: 10.1007/s00405-014-3108-1. Epub 2014 Jun 3. Eur Arch Otorhinolaryngol. 2015. PMID: 24890977 Review.
-
Surgical options in undifferentiated thyroid carcinoma.World J Surg. 2007 May;31(5):969-77. doi: 10.1007/s00268-007-0776-7. World J Surg. 2007. PMID: 17483987 Review.
-
A Remarkable and Durable Response to Sintilimab and Anlotinib in the First-Line Treatment of an Anaplastic Thyroid Carcinoma without Targetable Genomic Alterations: A Case Report.Onco Targets Ther. 2021 Apr 20;14:2741-2746. doi: 10.2147/OTT.S305196. eCollection 2021. Onco Targets Ther. 2021. PMID: 33907417 Free PMC article.
-
Anaplastic thyroid carcinoma: pathogenesis and emerging therapies.Clin Oncol (R Coll Radiol). 2010 Aug;22(6):486-97. doi: 10.1016/j.clon.2010.03.013. Epub 2010 Apr 24. Clin Oncol (R Coll Radiol). 2010. PMID: 20418080 Free PMC article. Review.
-
Primary Versus Secondary Anaplastic Thyroid Carcinoma: Perspectives from Multi-institutional and Population-Level Data.Endocr Pathol. 2021 Dec;32(4):489-500. doi: 10.1007/s12022-021-09692-z. Epub 2021 Sep 24. Endocr Pathol. 2021. PMID: 34559383
MeSH terms
LinkOut - more resources
Medical